Ventana Medical Sytems, Inc.
Country not established
- Devices
- 1
What Ventana Medical Sytems, Inc. makes
Ventana Medical Systems, Inc. manufactures immunohistochemical (IHC) reagents, specifically the CONFIRM Anti-Progesterone Receptor (1E2) Rabbit Monoclonal Primary Antibody, used for identifying progesterone receptor expression in tissue samples.
This product is classified as a Class II medical device under FDA regulations and is listed via the 510(k) pathway. The company is based in the United States.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Ventana Medical Sytems, Inc. have in the registry?
The registry currently lists 1 device for Ventana Medical Sytems, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Ventana Medical Sytems, Inc.'s devices?
Among its 1 most recently registered device, Ventana Medical Sytems, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Ventana Medical Sytems, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Ventana Medical Sytems, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Ventana Medical Sytems, Inc. in the registry?
The most recently registered devices listed for Ventana Medical Sytems, Inc. include CONFIRM ANTI-PROGESTORONE RECEPTOR (1E2) RABBIT MONOCLONAL PRIMARY ANTIBODY.